Immune enhancement and anti-tumour activity of IL-23. (Q36468947)

14 August 2017

1 reference

title

Immune enhancement and anti-tumour activity of IL-23. (English)

1 reference

14 August 2017

Jing-Sheng Hao

1

1 reference

PubMed ID

16676182

14 August 2017

Bao-En Shan

series ordinal

2

1 reference

14 August 2017

5 May 2006

1 reference

Cancer Immunology, Immunotherapy

14 August 2017

1 reference

14 August 2017

55

1 reference

14 August 2017

1426-1431

1 reference

14 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-006-0171-5

14 August 2017

0 references

cites work

Regulation of virus-induced IL-12 and IL-23 expression in human macrophages

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0171-5

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0171-5

Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0171-5

Antitumor and antimetastatic activity of IL-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0171-5

IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0171-5

10.1007/S00262-006-0171-5

21 January 2018

Identifiers

DOI

1 reference

release_iwcy5tj3endfpar5c75i47f22m

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iwcy5tj3endfpar5c75i47f22m

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16676182

1 reference

PubMed ID

16676182